5 Cost Savings Opportunities When Selling Surplus Biopharmaceutical Equipment
Source: Federal Equipment Company
By Matt Hicks, Chief Operating Officer and General Counsel, Federal Equipment Company
Selling or disposing of surplus and unused pharmaceutical manufacturing and pharmaceutical packaging equipment can provide cash to your business from otherwise idled “assets.” That cash can be used for operations or new capital projects. Continued storage of that equipment costs your company money. Selling idled equipment can also generate significant cost savings opportunities for your business.
Here are five cost saving opportunities beyond cash generation that can be obtained by selling your excess capital equipment.
VIEW THE ARTICLE! Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online X
Subscribe to Bioprocess Online